Harris JE - Search Results

1

Melanocytes in psoriasis: convicted culprit or bullied bystander?

Strassner JP, Rashighi M, Harris JE. Strassner JP, et al. Among authors: harris je. Pigment Cell Melanoma Res. 2016 May;29(3):261-3. doi: 10.1111/pcmr.12470. Pigment Cell Melanoma Res. 2016. PMID: 26929278 Free PMC article. No abstract available.

2

A network of high-mobility group box transcription factors programs innate interleukin-17 production.

Malhotra N, Narayan K, Cho OH, Sylvia KE, Yin C, Melichar H, Rashighi M, Lefebvre V, Harris JE, Berg LJ, Kang J; Immunological Genome Project Consortium. Malhotra N, et al. Among authors: harris je. Immunity. 2013 Apr 18;38(4):681-93. doi: 10.1016/j.immuni.2013.01.010. Epub 2013 Apr 4. Immunity. 2013. PMID: 23562159 Free PMC article.

3

CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.

Rashighi M, Agarwal P, Richmond JM, Harris TH, Dresser K, Su MW, Zhou Y, Deng A, Hunter CA, Luster AD, Harris JE. Rashighi M, et al. Among authors: harris je, harris th. Sci Transl Med. 2014 Feb 12;6(223):223ra23. doi: 10.1126/scitranslmed.3007811. Sci Transl Med. 2014. PMID: 24523323 Free PMC article.

4

Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo.

Agarwal P, Rashighi M, Essien KI, Richmond JM, Randall L, Pazoki-Toroudi H, Hunter CA, Harris JE. Agarwal P, et al. Among authors: harris je. J Invest Dermatol. 2015 Apr;135(4):1080-1088. doi: 10.1038/jid.2014.529. Epub 2014 Dec 18. J Invest Dermatol. 2015. PMID: 25521459 Free PMC article.

5

Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA).

Harris JE, Rashighi M, Nguyen N, Jabbari A, Ulerio G, Clynes R, Christiano AM, Mackay-Wiggan J. Harris JE, et al. J Am Acad Dermatol. 2016 Feb;74(2):370-1. doi: 10.1016/j.jaad.2015.09.073. Epub 2015 Dec 11. J Am Acad Dermatol. 2016. PMID: 26685721 Free PMC article. No abstract available.

6

Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.

Rashighi M, Harris JE. Rashighi M, et al. Among authors: harris je. Ann Transl Med. 2015 Dec;3(21):343. doi: 10.3978/j.issn.2305-5839.2015.11.36. Ann Transl Med. 2015. PMID: 26734651 Free PMC article. No abstract available.

7

Understanding autoimmunity of vitiligo and alopecia areata.

Rork JF, Rashighi M, Harris JE. Rork JF, et al. Among authors: harris je. Curr Opin Pediatr. 2016 Aug;28(4):463-9. doi: 10.1097/MOP.0000000000000375. Curr Opin Pediatr. 2016. PMID: 27191524 Free PMC article. Review.

8

Serum chemokines herald disease activity and treatment response in vitiligo patients.

Rashighi M, Harris JE. Rashighi M, et al. Among authors: harris je. Br J Dermatol. 2016 Jun;174(6):1190-1. doi: 10.1111/bjd.14671. Br J Dermatol. 2016. PMID: 27317283 No abstract available.

9

Sampling Serum in Patients With Vitiligo to Measure Disease Activity in the Skin.

Rashighi M, Harris JE. Rashighi M, et al. Among authors: harris je. JAMA Dermatol. 2016 Nov 1;152(11):1187-1188. doi: 10.1001/jamadermatol.2016.2501. JAMA Dermatol. 2016. PMID: 27557448 No abstract available.

10

Understanding mechanisms of autoimmunity through translational research in vitiligo.

Strassner JP, Harris JE. Strassner JP, et al. Among authors: harris je. Curr Opin Immunol. 2016 Dec;43:81-88. doi: 10.1016/j.coi.2016.09.008. Epub 2016 Oct 17. Curr Opin Immunol. 2016. PMID: 27764715 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

615 results

Search Page